While Progyny Inc has overperformed by 1.38%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PGNY fell by -54.31%, with highs and lows ranging from $42.08 to $13.39, whereas the simple moving average fell by -40.99% in the last 200 days.
On November 13, 2024, Truist Downgraded Progyny Inc (NASDAQ: PGNY) to Hold. A report published by JMP Securities on September 19, 2024, Downgraded its rating to ‘Mkt Perform’ for PGNY. Leerink Partners also Downgraded PGNY shares as ‘Market Perform’, setting a target price of $25 on the company’s shares in a report dated August 07, 2024. Canaccord Genuity August 07, 2024d the rating to Hold on August 07, 2024, and set its price target from $37 to $24. BTIG Research August 07, 2024d its ‘Buy’ rating to ‘Neutral’ for PGNY, as published in its report on August 07, 2024. JMP Securities’s report from July 16, 2024 suggests a price prediction of $36 for PGNY shares, giving the stock a ‘Mkt Outperform’ rating. KeyBanc Capital Markets also rated the stock as ‘Sector Weight’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of Progyny Inc (PGNY)
Further, the quarter-over-quarter increase in sales is 2.04%, showing a positive trend in the upcoming months.
To gain a thorough understanding of Progyny Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of 12.05% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.62, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and PGNY is recording an average volume of 2.29M. On a monthly basis, the volatility of the stock is set at 4.16%, whereas on a weekly basis, it is put at 4.62%, with a gain of 10.73% over the past seven days. Furthermore, long-term investors anticipate a median target price of $19.25, showing growth from the present price of $15.48, which can serve as yet another indication of whether PGNY is worth investing in or should be passed over.
How Do You Analyze Progyny Inc Shares?
A leading company in the Health Information Services sector, Progyny Inc (PGNY) is based in the USA. When comparing Progyny Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 26.67, there is a growth in quarterly earnings of -29.51%.
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 15.12%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 90.18% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
PGNY shares are owned by institutional investors to the tune of 90.18% at present.
